News Focus
News Focus
Post# of 257269
Next 10
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

Re: linhdtu post# 157231

Thursday, 02/21/2013 8:20:15 PM

Thursday, February 21, 2013 8:20:15 PM

Post# of 257269
Even though GSK won against Teva/Par, they at least hedged by settling with Apotex which will allow generic Lovaza on the market 2 years before the second patent expires in 2017.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today